Breath of Life: Heart Disease Link to Developmental Hypoxia.
Dino A GiussaniPublished in: Circulation (2021)
Heart disease remains one of the greatest killers. In addition to genetics and traditional lifestyle risk factors, we now understand that adverse conditions during pregnancy can also increase susceptibility to cardiovascular disease in the offspring. Therefore, the mechanisms by which this occurs and possible preventative therapies are of significant contemporary interest to the cardiovascular community. A common suboptimal pregnancy condition is a sustained reduction in fetal oxygenation. Chronic fetal hypoxia results from any pregnancy with increased placental vascular resistance, such as in preeclampsia, placental infection, or maternal obesity. Chronic fetal hypoxia may also arise during pregnancy at high altitude or because of maternal respiratory disease. This article reviews the short- and long-term effects of hypoxia on the fetal cardiovascular system, and the importance of chronic fetal hypoxia in triggering a developmental origin of future heart disease in the adult progeny. The work summarizes evidence derived from human studies as well as from rodent, avian, and ovine models. There is a focus on the discovery of the molecular link between prenatal hypoxia, oxidative stress, and increased cardiovascular risk in adult offspring. Discussion of mitochondria-targeted antioxidant therapy offers potential targets for clinical intervention in human pregnancy complicated by chronic fetal hypoxia.
Keyphrases
- endothelial cells
- cardiovascular disease
- pregnancy outcomes
- oxidative stress
- risk factors
- metabolic syndrome
- preterm birth
- type diabetes
- pulmonary hypertension
- randomized controlled trial
- pregnant women
- high fat diet
- stem cells
- healthcare
- mental health
- dna damage
- high throughput
- weight loss
- current status
- insulin resistance
- physical activity
- bone marrow
- cancer therapy
- emergency department
- ischemia reperfusion injury
- induced pluripotent stem cells
- cardiovascular risk factors
- skeletal muscle
- single cell
- smoking cessation
- blood flow
- drug delivery
- case control
- anti inflammatory
- replacement therapy